Skip to main content
Premium Trial:

Request an Annual Quote

Genematrix HPV Detection Test Nabs CE Mark

NEW YORK – South Korean diagnostics firm Genematrix announced on Tuesday that its new human papillomavirus detection kit has received CE marking.

The NeoPlex HPV29 Detection kit can collectively detect 29 genotypes of HPV and simultaneously identify the virus genotype according to the risk of cervical cancer. It uses the firm's proprietary C-Tag multiplex RT-PCR technology.

An unnamed official for the company noted in a statement that "by reducing the turnaround time by more than an hour compared to existing products in the market, it is possible to obtain a same-day report in just half a day."

The firm also offers multiplex tests for COVID-19, respiratory tract infections, sexually transmitted infections, and gastrointestinal tract infections.

In May 2020, the firm's NeoPlex COVID-19 Detection Kit received Emergency Use Authorization from the US Food and Drug Administration.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.